So-Young International Inc. reported total revenues of RMB378.7 million (US$52.9 million) for the second quarter ended June 30, 2025, a 7.0% decrease year-over-year from RMB407.4 million. The company recorded a net loss attributable to shareholders of RMB36.0 million (US$5.0 million), compared to a net income of RMB18.9 million in Q2 2024.
A significant milestone was achieved as aesthetic treatment services emerged as the largest revenue contributor, generating RMB144.4 million (US$20.1 million). This represents a remarkable 426.1% increase year-over-year from RMB27.4 million in the same period of 2024, underscoring the success of the company's vertically integrated strategy.
As of June 30, 2025, So-Young operated 29 aesthetic centers across China, solidifying its position as a leading light medical aesthetics brand. For the third quarter of 2025, the company expects aesthetic treatment services revenues to be between RMB150.0 million and RMB170.0 million, representing a 230.5% to 274.6% increase year-over-year.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.